Olverembatinib dimesylate

Abl, Abl (E255K), Abl (H396P), Abl (M351T), Abl (Q252H), Bcr-Abl, Bcr-Abl (T315I), BcrAbl, breakpoint, cluster, nonphosphorylated, linase, inhibit, imatinib, Olverembatinib, Olverembatinib dimesylate, Olverembatinib Dimesylate, HQP 1351, HQP1351, HQP-1351, HQP1351 dimesylate, Inhibitor, GZD 824, GZD 824 Dimesylate, GZD824, GZD-824, GZD824 Dimesylate, GZD-824 Dimesylate, region-Abelson, phosphorylated, resistance

DMSO:93 mg/mL (128.32 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble) ; H2O:92 mg/mL (126.94 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (4.55 mM)